Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 2/2006

01-05-2006 | Special article

Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry

Authors: Keiichi Maruyama, Michio Kaminishi, Ken-ichi Hayashi, Yoh Isobe, Ichiro Honda, Hitoshi Katai, Kuniyoshi Arai, Yasuhiro Kodera, Atsushi Nashimoto, Japanese Gastric Cancer Association Registration Committee

Published in: Gastric Cancer | Issue 2/2006

Login to get access
Metadata
Title
Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry
Authors
Keiichi Maruyama
Michio Kaminishi
Ken-ichi Hayashi
Yoh Isobe
Ichiro Honda
Hitoshi Katai
Kuniyoshi Arai
Yasuhiro Kodera
Atsushi Nashimoto
Japanese Gastric Cancer Association Registration Committee
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 2/2006
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-006-0370-y

Other articles of this Issue 2/2006

Gastric Cancer 2/2006 Go to the issue

Editorial

Preoperative diagnosis of lymph node metastasis: a dream?

Original article

Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10

Original article

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer

Case report

Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy

Editorial

Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer

Editorial

Neoadjuvant S-1 and cisplatin for gastric carcinoma: there will be more to come
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits